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ABSTRACT 
 
OBJECTIVE: The objective of this systematic review is to determine whether or not dietary 
intervention has an effect on the progression and ultimately the treatment of Prostate cancer.  
STUDY DESIGN: Review of three English language primary studies published in 2007, 2008, 
and 2009.  
DATA SOURCES: Two randomized control trials and one cohort study studying the effects of 
dietary intervention on the progression of prostate cancer found using OVID and Medline. 
OUTCOME MEASURED: Outcomes were measured by further progression or recurrence of 
prostate cancer. This was possible by looking at reduced tumor proliferation, reduced PSA 
levels, wt. changes, gene expression changes, food consumption, and number of events. The 
numbers of events of prostate cancer recurrence of progression were defined as the first of 
following events: prostate cancer death, metastases, biochemical recurrence, or initiation of a 
second treatment.  
RESULTS: All three published studies included in this review provided evidence to suggest that 
post-diagnostic dietary intervention can have an effect in some way on the progression of 
prostate cancer. 
CONCLUSIONS:  The results of this review demonstrate that there is currently enough evidence 
to suggest that dietary intervention can possibly have an effect on the course or change the 
progression of prostate cancer after diagnosis and before treatment. Whether studies showed an 
increased risk of progression, or a reduction in tumor growth, there is enough information to 
establish a significant change in progression as a result of dietary influence. Because the results 
of the two RCT’s and one Cohort study reviewed reported varying results as to what types of 
dietary interventions may play a specific role, more research is required to explore the definite 
types of food, amounts, and their mechanisms in influencing the outcome of prostate cancer 
before it can be considered as adjunct treatment.   
KEY WORDS: Prostate, Prostate Cancer, Diet, Dietary Intervention, Reduction, Progression, 
Treatment 
 
 
 
 
                    
INTRODUCTION 
 Prostate cancer is a very common malignancy of the prostate gland, one of the structures 
that make up part of the male reproductive system. The disease is characterized on a basic level 
by changes in the DNA of the prostate cells, with the majority developing from gland cells 
usually leading to a relatively slow growing adenocarcinoma.
1
 While the disease can affect men 
of all ages, the majority of men affected are over age 40, with 1 in 6 of all men affected in their 
lifetime. Prostate cancer is currently the 2
nd
 leading cause of cancer death in American men, with 
approximately 2.1 million men currently living with prostate cancer in the US. This year about 
217,730 new cases will be diagnosed with about 32,050 of those men dying. The disease is so 
common that has been shown that 70-90% of men by age 80 have prostate cancer at autopsy but 
were unaware before death. 
1
 
Because of its universal nature, prostate cancer is a disease that crosses over into many 
scopes of PA practice and is something that many practitioners must become familiar with 
treating and diagnosing. Currently available treatments can be effective, but depend on the extent 
of cancer spread, and are often expensive. The cumulative cost of treating prostate cancer is 
estimated to be, on average, $42,570 over 5 years of treatment.
2
 The usual methods used to treat 
prostate cancer are observation with close monitoring, surgery via radical or robotic 
prostatectomy, radiation therapy via external beam radiation or internal brachytherapy, 
cryosurgery, hormone therapy, and chemotherapy. 
Currently, the exact cause of prostate cancer is unknown, although there are known risk 
factors. Risk factors include African American race, family history, genetics, obesity, and diet. 
Because diet is a known risk factor for the disease, and is believed to have an influence on the 
development and progression of the disease, the prospect of adding something such as dietary 
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intervention to the treatment plan, if shown to be beneficial, could be a relatively simple and cost 
effective method for patients to bolster the care and slow the progression of prostate cancer.  
OBJECTIVE 
 The objective of this systematic review is to determine whether or not dietary 
intervention has an effect on the progression and ultimately the treatment of prostate cancer.  
METHODS 
 All three studies used in this review required a population of men with diagnosed prostate 
cancer whether it was biopsy-confirmed or clinically localized. All interventions were strictly 
dietary and included methods such as the incorporation of flaxseed, a low-fat, low-glycemic load 
diet, or the consumption of processed and unprocessed red meat, poultry, fish, and eggs. 
Comparisons were made between control groups continuing with their usual diet and groups 
varying in their consumption of each food. The outcomes looked at included the progression of 
prostate cancer as well as the recurrence of prostate cancer, both which qualify as patient 
oriented evidence that matters (POEM). Studies included a RCT comparing men who began a 
flaxseed supplementation to men continuing their usual diet, a RCT comparing men who began a 
low-fat/low-glycemic load diet to men continuing their usual diet, and a cohort study looking at 
post-diagnostic consumption of processed and unprocessed red meat, poultry, fish, and eggs for 2 
years.  
 A detailed search was completed by the author using key words such as prostate, prostate 
cancer, diet, dietary intervention, reduction, treatment, and progression. All articles were 
published in English and in peer-reviewed journals. All literature searches and the selection of 
studies for this review were performed by the author. Literature searches were performed for 
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articles via OVID, Medline and Cochrane databases and were selected based on relevance and 
that the outcomes of the studies mattered to patients. Inclusion criteria included studies that were 
randomized, controlled, prospective, and were based on patient oriented outcome. Studies were 
also chosen based on content including a demographic already diagnosed with prostate cancer. 
Under these criteria, two RCT’s and one cohort study were selected and included in this review. 
The statistics used in these studies were p-values with a value of <0.05 being statistically 
significant and 95% confidence intervals. 
OUTCOMES MEASURED 
 The primary outcome measured in all of the studies included was the status of the 
prostate cancer after some sort of a dietary intervention in terms of whether it got worse, slowed 
progression, or if it had previously been in remission, whether or not it returned. This was 
measured by looking for reduced tumor proliferation rates (indicating a slower growing tumor), 
reduced PSA levels (decrease between baseline and follow up levels indicating effective 
treatment), wt changes (kg), gene expression changes, food consumption (median values), and 
number of events. Numbers of events of prostate cancer recurrence or progression were defined 
as the first of the following: prostate cancer death, metastases, biochemical recurrence, or 
initiation of a second treatment.  
RESULTS 
 The major characteristics of the trials used in this study are displayed in Table 1. Results 
pertaining to the primary outcome were presented as continuous data, not convertible to 
dichotomous format for all three studies. Test statistics provided included p-values and 
confidence intervals pertaining to the method of measuring the outcome in each individual study.   
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Table 1. Table of demographics of included studies 
Study Type # Pts Age 
(yrs) 
Inclusion Criteria Exclusion Criteria W/
D 
Interventions 
Denmark-
Wahnefried 
W (1) 
RCT 161 36-73 Male w/ bx-confirmed 
prostatic CA electing 
prostatectomy as their 
primary treatment; at least 
21 days from scheduled 
surgery; must be mentally 
competent; must be Eng. 
speaking/writing w/ 
telephone access 
Recent flaxseed use and/or 
adherence to a diet < 30% 
kilocalories from fat; 
dietary supplements started 
w/in the past 3 mos; 
current abx use; hx of 
hormonal or other 
neoadjuvant therapies 
7.5
% 
Flaxseed 
Supplementatio
n x 30 days: 
10g days 1-3, 
20g days 4-6, 
30g days 7-30 
Lin DW (2) RCT 8 59-69 Men w/ clinically localized 
prostate CA who select 
radical prostatectomy; have 
ability to implement dietary 
change; have participated in 
an independent protocol that 
collected and stored 4 
prostate tissue cores at the 
time of diagnostic prostate 
bx 
No concurrent diseases 
requiring dietary 
modification; no current 
use of hormonal 
treatments; BMI >20kg/m2 
and <35kg/m2 
0 Initiation of 
Low-fat/low-
glycemic diet: 
20% energy 
from fat and 
total daily 
glycemic load 
<100 
Richman 
EL (3) 
Cohort 
Study 
1294 Not 
specif
ied 
Men who had bx-proven 
prostate CA; men w/out 
recurrence or progression as 
of 2004-05 participating in 
the Cancer of the Prostate 
Strategic Urologic Research 
Endeavor; men must have 
completed the baseline Diet 
& Lifestyle CaPSURE 
survey between 4/2004 and 
11/2005 
Men with advanced or 
metastatic disease at dx; 
men w/ no treatment info.; 
men w/ no f/u beyond Diet 
& Lifestyle survey; men w/ 
prostate cancer that had 
progressed before they 
completed the surgery; 
men w/ unreasonable 
energy intake (<800 or 
>4200 kcal/d) 
38 Post-diagnostic 
consumption of 
processed and 
unprocessed 
meat, fish, 
poultry, and 
eggs x 2 years 
 
In the multisite, randomized control trial included by Demark-Wahnefried et al, prostate 
cancer patients scheduled at least 21 days before prostatectomy were randomly assigned to either 
control or a dietary intervention arm.
3
 After an average of 30 days on either the flaxseed or 
control diet, Demark-Wahnefried et al reported prostate cancer tumor proliferation rates as well 
as baseline and follow up PSA levels (Table 2). When looking at results in Table 2, TPR’s 
(tumor proliferation rates) were significantly lower in the flaxseed, or experimental arm. The 
TPR of the control arm at the end of the study was 3.23, while the TPR for the experimental arm 
was 1.66. The significance of this difference was demonstrated through a statistically significant 
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p-value of 0.0013 (<0.05). Significant PSA changes between baseline and follow up for either 
study arm were not observed in this study. The results of this study demonstrate a control 
baseline PSA of 5.3 with a 95% CI (2.42-3.92) with a follow up level of 4.9 with a 95% CI (3.5-
6.2), whereas the experimental arm baseline is 6.2 with a 95% CI (4.8-7.7) and follow up level is 
6.4 with a 95% CI (5.0-7.0). The changes in PSA level after intervention from median baseline to 
median follow up demonstrated a p–value of 0.286 that is not statistically significant when 
comparing both arms of the study (Table 2).  
In the  randomized control trial by Lin et al, men who were newly diagnosed with 
prostate cancer were randomly assigned to either a “standard American” diet control arm which 
consisted of men continuing on their usual diet, or an experimental one including a low-fat/low-
glycemic load.
4
 In this study, the average weight change was reported for both arms. As seen in 
Table 2, a post-intervention weight change of -5.3kg in the experimental group was noted, while 
a weight change of only 0.8g was reported for the control group. A p-value for the weight change 
between the two groups was found to be 0.02 and statistically significant with a 95% CI (1.6-
10.5). Gene expression was measured using cDNA microarray hybridization confirmed with 
quantitative reverse transcription-PCR. This data was also reported in both groups after the 
course of the study. For the control arm, no differences in transcript expression of genes were 
found to be statistically significant. In the experimental arm, it was reported that 23 (0.46%) of 
5711 cDNAS with measurable expression were significantly altered, and although a p-value was 
not stated, it was reported to be <0.05 and statistically significant (Table 2). 
 In the Cohort study by Richman et al, men with biopsy-proven prostate cancer were 
selected and their diets were followed for 2 years.
5
 Associations between consumption levels of 
four meat groups and eggs and relative risk of progression of prostate cancer were analyzed. 
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Groups included processed and unprocessed red meat, fish, poultry, and eggs. Richman et al 
reported their data by breaking down each food group into quartiles and quantiles based on what 
food type and how much of each was being consumed. The number of events within each 
quartile and quantile was recorded with number of events being defined as prostate cancer 
deaths, bone metastases from prostate cancer, biochemical recurrence, or initiation of secondary 
treatment. Because the data was broken down in this fashion, and provided in a very different 
manner than the RCT’s included, a separate results table for this Cohort study was created as 
Table 3. The total number of events for each quartile/group can be seen in Table 3. After data 
was collected, poultry data was found to be border-line and that category was thus broken down 
and reanalyzed as poultry with skin and poultry without skin groups. It is important to note that 
individualized number of events for that division was not given. Relative risks of progression 
were calculated by comparing the risk of progression for men in the upper quantiles relative to 
men in the lowest quantile. Hazard ratios were calculated with a 95% CI for comparison of the 
highest with the lowest quantile and p-values for each were analyzed. Of all the groups, the p-
values found to be statistically significant were those from the poultry with skin and egg groups. 
In the poultry with skin group, a p-value of 0.003 (<0.05) was found to be statistically significant 
with a HR (95% CI) of 2.26 (1.36-3.76). Data showed that men in the highest tertile of poultry 
with skin had more than double the risk of prostate cancer progression compared to men in the 
lowest tertile. Data also shows in the egg group, a p-value 0.05 was found to be statistically 
significant with a HR (95% CI) of 2.02 (1.10-3.72). This data represented an observed significant 
2-fold increased risk of prostate cancer progression among men in the highest quartile of egg 
intake compared with men in the lowest (Table 3).  
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Table 2. Methods of measure and results for study arms with statistical analysis of significance 
Study Methods of Measure Control Results Intervention Results SS 
Demark-
Wahnefried et 
al 
TPR  
 
PSA levels at 
Baseline and at F/U 
TPR = 3.23, 
95% CI (2.42-3.92) 
Baseline PSA = 5.3, 
95% CI (3.7-5.8) 
F/U PSA = 4.9, 95% CI 
(3.5-6.2) 
TPR = 1.66, 
95% CI (1.13-2.64) 
Baseline PSA = 6.2, 95% 
CI (4.8-7.7) 
F/U PSA = 6.4, 95% CI 
(5.0-7.0) 
TPR p-value = 
0.0013* 
 
PSA Changes p-
value = 0.286, NS 
 
Lin et al Post Intervention 
Weight Change (kg) 
 
Gene Expression 
Changes 
Wt = 0.8kg 
 
 
 
No differences in 
transcript expression  
Wt = -5.3kg 
 
 
 
23 (0.46%) of 5711 
cDNAs were altered 
Diff in wt change = 
6.1kg, 95% CI 
(1.6-10.5), p-value 
= 0.02*  
Control: gene 
expression p-value 
NS 
Intervention: gene 
expression p-value 
is <0.05* 
(exact p-values not 
given) 
Richman et al  Number of Events  **See Table 3 **See Table 3 **See Table 3 
TPR = Tumor Proliferation Rates, PSA = Prostate Specific Antigen, f/u = follow up, CI = Confidence Interval, * = 
statistically significant (p-value <0.05), SS = statistical significance, NS = not significant, **Note: Data for Richman 
et al provided in Table 3 
Table 3. Statistical Analysis of Number of Events in each food group & quartile (Richman et al) 
Cohort Study – 
Richman et al 
Quartile 1 
Number of 
events 
Quartile 2 
Number of 
events 
Quartile 3 
Number of 
events 
Quartile 4 
Number of 
events 
P value, HR 
Processed Red Meat 29/310 32/372 21/275 45/337 p-value = 0.18, HR (95% 
CI) = 1.30 (0.78,2.17) 
Unprocessed Red Meat  30/324 38/371 26/296 33/303 p-value = 0.65, HR (95% 
CI) = 0.95 (0.55,1.66) 
Fish 36/348 21/275 34/324 36/347 p-value = 0.46, HR (95% 
CI) = 1.13 (0.70,1.84) 
Poultry 33/380 24/224 35/344 35/346 *p-value for poultry w/ 
skin = 0.003, HR (95% 
CI) = 2.26 (1.36, 3.76) 
p-value for poultry w/out 
skin= 0.87 
Eggs 24/319 27/267 51/532 25/176 *p-value = 0.05, HR 
(95% CI) = 2.02 
(1.10,3.72) 
HR = Hazard Ratio, CI = Confidence Interval, *p-value = significant as defined as <0.05 
Compliance to each diet was measured differently for each study. In the RCT by 
Demark-Wahnefried et al, compliance was encouraged by having participants keep logs of daily 
intakes and by having participants return any unused packets of flaxseed to monitor usage. 
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Adherence to the diet was also supported by noting higher lignin intakes and expression within 
urine and seminal fluid. In the RCT by Lin et al, dietary compliance was encouraged by weekly 
scheduled telephone calls between participants and the study nutritionist provided, as well as 
additional weekly unscheduled and blinded telephone interviewers making 24h dietary recalls. 
Methods to ensure compliance were not mentioned for the Cohort Study by Richman et al.  
In mentioning the safety of these studies, Demark-Wahnefried et al was the only study to 
mention side effects. They reported that throughout the study there was a lack of, or only mild 
side effects reported for participants involved in flaxseed supplementation. Several participants 
in this study were noted to report symptoms of low libido or erectile dysfunction, however no 
differences were ultimately observed between the control and experimental arm for this or any 
other side effect. Other studies included failed to mention any adverse side effects of dietary 
change and all indicated that the interventions were tolerated sufficiently well. 
DISCUSSION 
The articles used in this review demonstrate that dietary intervention in many areas after 
the diagnosis of prostate cancer may play a role in its progression. While there are many aspects 
of dietary intervention discussed in this paper, and while much more research needs to be done 
on the subject and how it may someday be used as co-treatment, the prospect for knowledge on 
how diet can influence the progression of prostate cancer is vast. Exploring this research is 
important because the dietary methods of intervention examined in these studies are easily 
accessible, cost effective, and readily available for patients everywhere who have been recently 
diagnosed with prostate cancer.  
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Certainly, these studies have their limitations. The study by Demark-Wahnefried et al 
was only an average of 30 days, which could have limited the potential for more extensive and 
thorough data over a longer period of time. In the study by Lin et al, a major limitation was the 
small sample size of 8, as well as a small number of genes that were analyzed within the prostate 
epithelium. Another important limitation point is that those participating in the experimental arm 
lost a significant amount of weight compared to those on the control diet simply from the change 
from their baseline. It might be possible that the effects the researchers are assuming are from 
dietary influence are more linked to the actual reduction in body mass as a result of the change in 
diet. In the study by Richman et al, limitations included a short follow-up, small number of 
prostate deaths or metastases, and lack of pre-diagnostic dietary data. Because men were 
recruited after diagnosis of prostate cancer, the dietary information of participants and its 
influence prior to the study could not be examined. It is possible that a lack of dietary data prior 
to the study could lead to a misrepresentation of the patient’s overall dietary history and thus the 
strength of its influence. 
CONCLUSION  
 In conclusion, the studies reviewed demonstrate that there is evidence to show that 
dietary intervention can have an effect on the progression of prostate cancer. Although more 
research needs to be done to investigate the specific nature of this link, and what other types of 
food play a role, at this time there is enough evidence to support an association between a change 
in diet and some change in the course or progression of prostate cancer. 
At this time, it appears that flaxseed supplementation post-diagnostically in prostate 
cancer is safe and associated with biological changes, which may protect against the progression 
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of prostate cancer. Hope that initiation of flaxseed into one’s diet after diagnosis can potentially 
slow down the progression appears promising at this time. However, while it appears that 
flaxseed supplementation has been associated with a reduction in tumor proliferation rates (or in 
other words, has been shown to slow the rate of tumor growth), there has not been a significant 
association found between flaxseed in one’s diet and a change in PSA level at this time. Because 
of the inconclusive data on the effects of flaxseed on PSA levels and other measurements 
involved with tracking the progress of prostate cancer treatment, future studies need to 
investigate further the exact mechanism and influence this supplementation has on the prostate 
epithelium growth.  
Results for consumption of poultry with skin and eggs after diagnosis demonstrated a 
positive association between these food groups and a 2-fold increased risk of progression among 
men with localized disease based on an increased number of events in those populations. 
Although, it appears that data supports this increased risk, the exact mechanism needs to be 
explored further, as well as the specific amount that is associated with this risk in the future 
alongside a more extensive dietary history.  
Lastly, the study looking at the incorporation of a low-fat/low-glycemic diet showed a 
statistically significant effect of dietary change, and ultimately a significant change in weight, on 
gene expression within prostate epithelium. The implementation of this diet seemed to be 
associated with significant genetic changes in expression within the cancerous tissue of the 
prostate. At this time, because it’s hard to decipher whether or not the genetic changes that 
occurred were due to the diet itself or instead the resultant weight change, the data is 
inconclusive as to whether or not this specific diet specifically can change the progression of 
cancer. Instead, the data supporting gene expression change as a result of changes in diet simply 
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opens up the door to study the link between diet, prostate cancer, and obesity. Because the 
changes could be more due to the reduction in body mass and because it is difficult to say at this 
time if the genetic changes truly have an effect on the course of the cancer, more research also 
needs in the area of gene expression usage in general as a measure of cancerous change. 
 In conclusion, while it appears there is enough evidence to establish a link between 
changing one’s diet and altering the progression of prostate cancer, more research needs to be 
done to definitively determine what types of dietary intervention can potentially slow down or 
alternatively worsen the progression of prostate cancer and how it can be used as adjunct 
treatment in the future. If a more direct link or mechanism can be established, it’s possible that 
dietary intervention may be the basis for co-treatment or even long-term prevention of prostate 
cancer in the future. Further studies are warranted to evaluate more specific effects of dietary 
intervention on the progression of prostate cancer and how it can possibly be incorporated into a 
treatment plan. 
 Future studies would benefit from larger sample sizes, longer studies, more in depth 
pooling of genes from participants, investigation into the worth of genetic expression changes as 
a reflection of changes in cancer status, and more extensive information on each participants’ 
dietary history. This might prove to be more helpful in terms of reflecting the long term 
influences of diet on each patient, as well as representing a greater number of people and thus 
prostate cancer in general more accurately.  
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